To squeeze or not to squeeze. The ARISE-FLUIDS trial
The article reviews the ARISE-FLUIDS trial, which compared early vasopressors with restricted fluids versus higher fluid volumes and later vasopressors in septic shock patients presenting to the ED. The study concluded that neither approach resulted in a greater number of days alive at day 90 than the other. Clinically, this suggests caution regarding current resuscitation practices, as the trial found no benefit for early vasopressor use with restricted fluids over higher fluid volumes.
The article reviews the ARISE-FLUIDS trial, which compared early vasopressors with restricted fluids versus higher fluid volumes and later vasopressors in septic shock patients presenting to the ED. The study concluded that neither approach resulted in a greater number of days alive at day 90 than the other. Clinically, this suggests caution regarding current resuscitation practices, as the trial found no benefit for early vasopressor use with restricted fluids over higher fluid volumes.
Show moreShow less
The article reviews the ARISE-FLUIDS trial, which compared early vasopressors with restricted fluids versus higher fluid volumes and later vasopressors in septic shock patients presenting to the ED. The study concluded that neither approach resulted in a greater number of days alive at day 90 than the other.